{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:04:40Z","timestamp":1759334680766,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.jfo.2017.11.012","type":"journal-article","created":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T01:38:24Z","timestamp":1523583504000},"page":"350-356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Uv\u00e9ites sous bioth\u00e9rapies et\/ou DMARDs en rhumatologie\u00a0: analyse de la base de donn\u00e9es d\u00e9clarative de la pharmacovigilance nationale fran\u00e7aise"],"prefix":"10.1016","volume":"41","author":[{"given":"L.","family":"Cabane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1700-8570","authenticated-orcid":false,"given":"S.","family":"Baillif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Baldin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Breuil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Euller-Ziegler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Tieuli\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2017.11.012_bib0125","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jbspin.2010.04.001","article-title":"Economic impact of rheumatoid arthritis (RA) biotherapies in France","volume":"77","author":"Maravic","year":"2010","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jfo.2017.11.012_bib0130","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/annrheumdis-2013-203582","article-title":"Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis","volume":"74","author":"Stolwijk","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jfo.2017.11.012_bib0135","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first International workshop. Ocular Involvement in Systemic Autoimmune Diseases","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2017.11.012_bib0140","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2147\/OPTH.S80972","article-title":"Epidemiology of uveitis in the mid-Atlantic United States","volume":"9","author":"Bajwa","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.jfo.2017.11.012_bib0145","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1001\/jamaophthalmol.2013.4237","article-title":"Incidence and prevalence of uveitis: results from the Pacific Ocular Inflammation Study","volume":"131","author":"Acharya","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jfo.2017.11.012_bib0150","first-page":"1","article-title":"Spectrum of uveitis in a german tertiary center: review of 474\u00a0consecutive patients","volume":"11","author":"Grajewski","year":"2015","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jfo.2017.11.012_bib0155","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.revmed.2010.07.020","article-title":"Clinical and etiological aspects of uveitis: a retrospective study of 121\u00a0patients referred to a tertiary centre of ophthalmology","volume":"32","author":"Nguyen","year":"2011","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.jfo.2017.11.012_bib0160","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.survophthal.2005.04.003","article-title":"Acute anterior uveitis and HLA-B27","volume":"50","author":"Chang","year":"2005","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jfo.2017.11.012_bib0165","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s12016-015-8518-3","article-title":"Ocular Involvement in Systemic Autoimmune Diseases","volume":"49","author":"Generali","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jfo.2017.11.012_bib0170","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1016\/j.jfo.2015.01.029","article-title":"Uveitis associated with spondylitis: It may be tuberculosis!","volume":"39","author":"Cabane","year":"2016","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2017.11.012_bib0175","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3109\/09273948.2014.986582","article-title":"Clinics of ocular tuberculosis","volume":"23","author":"Gupta","year":"2015","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jfo.2017.11.012_bib0180","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0248-8663(03)00140-1","article-title":"Chronic severe uveitis: classification, search for etiology and therapeutic approach","volume":"24","author":"Bodaghi","year":"2003","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.jfo.2017.11.012_bib0185","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1001\/archopht.1976.03910030120009","article-title":"Ocular toxoplasmosis in an adult receiving long-term corticosteroid therapy","volume":"94","author":"Nicholson","year":"1976","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2017.11.012_bib0190","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0002-9394(14)70532-X","article-title":"Causes of uveitis in the general practice of ophthalmology. UCLA Community-Based Uveitis Study Group","volume":"121","author":"McCannel","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2017.11.012_bib0195","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/ard.2008.089276","article-title":"Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry","volume":"69","author":"Greenberg","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jfo.2017.11.012_bib0200","first-page":"653","article-title":"Association between disease activity and risk of serious infections in subjects with rheumatoid arthritis treated with etanercept or disease-modifying anti-rheumatic drugs","volume":"32","author":"Emery","year":"2014","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jfo.2017.11.012_bib0205","doi-asserted-by":"crossref","first-page":"vi37","DOI":"10.1093\/rheumatology\/kes283","article-title":"Overview of safety of non-biologic and biologic DMARDs","volume":"51","author":"Ruderman","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.jfo.2017.11.012_bib0210","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1185\/03007995.2014.969368","article-title":"Comparing the risk of developing uveitis in patients initiating anti-tumor necrosis factor therapy for ankylosing spondylitis: an analysis of a large US claims database","volume":"30","author":"Wendling","year":"2014","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jfo.2017.11.012_bib0215","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3899\/jrheum.110865","article-title":"Scleritis: a paradoxical effect of etanercept? Etanercept-associated inflammatory eye disease","volume":"39","author":"Gaujoux-Viala","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jfo.2017.11.012_bib0220","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1002\/art.22918","article-title":"Do tumor necrosis factor inhibitors cause uveitis? A registry-based study","volume":"56","author":"Lim","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jfo.2017.11.012_bib0225","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/rheumatology\/kev434","article-title":"Factors associated with improvement in disease activity following initiation of etanercept in children and young people with Juvenile Idiopathic Arthritis: results from the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study","volume":"55","author":"Kearsley-Fleet","year":"2016","journal-title":"Rheumatology"},{"key":"10.1016\/j.jfo.2017.11.012_bib0230","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ajo.2016.07.016","article-title":"Anti-TNF\u03b1 treatment for HLA-B27-positive ankylosing spondylitis-related uveitis","volume":"170","author":"Kim","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2017.11.012_bib0235","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1007\/s10067-016-3426-3","article-title":"Different roles of TNF inhibitors in acute anterior uveitis associated with ankylosing spondylitis: state of the art","volume":"35","author":"Fabiani","year":"2016","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jfo.2017.11.012_bib0120","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.revmed.2014.07.008","article-title":"Biologics in uveitis","volume":"36","author":"Feurer","year":"2015","journal-title":"Rev Med Interne"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551218301037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551218301037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:08:11Z","timestamp":1759259291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551218301037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0181551218301037"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2017.11.012","relation":{},"ISSN":["0181-5512"],"issn-type":[{"type":"print","value":"0181-5512"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uv\u00e9ites sous bioth\u00e9rapies et\/ou DMARDs en rhumatologie\u00a0: analyse de la base de donn\u00e9es d\u00e9clarative de la pharmacovigilance nationale fran\u00e7aise","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2017.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}